Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys
Identifieur interne : 000311 ( France/Analysis ); précédent : 000310; suivant : 000312Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys
Auteurs : Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di PaoloSource :
- Synapse [ 0887-4476 ] ; 1999-06-01.
English descriptors
- KwdEn :
Abstract
The effect of denervation with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) of the dopamine (DA) nigrostriatal pathway on neurotensin (NT) receptor and DA transporter (DAT) in basal ganglia of monkeys (Macaca fascicularis) was investigated. The MPTP lesion induced a marked depletion of DA (90% or more vs. control) in the caudate nucleus and putamen. The densities of NT agonist binding sites labeled with [125I]NT and the NT antagonist binding sites labeled with [3H]SR142948A decreased by half in the caudate‐putamen of MPTP‐monkeys. In addition, the densities of [125I]NT and [3H]SR142948A binding sites markedly decreased (−77 and −63%, respectively) in the substantia nigra of MPTP‐monkeys. Levocabastine did not compete with high affinity for [125I]NT binding in the monkey cingulate cortex, suggesting that only one class of NT receptors was labelled in the monkey brain. An extensive decrease of [3H]GBR12935 DAT binding sites (−92% vs. Control) was observed in the striatum of MPTP‐monkeys and an important loss of DAT mRNA (−86% vs. Control) was observed in substantia nigra. Treatments for 1 month with either the D1 agonist SKF‐82958 (3 mg/kg/day) or the D2 agonist cabergoline (0.25 mg/kg/day) had no effect on the lesion‐induced decrease in NT and DAT binding sites or DAT mRNA levels. The decrease of striatal NT binding sites was less than expected from the decrease of DA content in this nucleus, suggesting only partial localization of NT receptors on nigrostriatal DAergic projections. These data also suggest that under severe DA denervation, treatment with D1 or D2 DA agonists does not modulate NT receptors and DAT density. Synapse 32:153–164, 1999. © 1999 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/(SICI)1098-2396(19990601)32:3<153::AID-SYN2>3.0.CO;2-X
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E04
- to stream Istex, to step Curation: 000E04
- to stream Istex, to step Checkpoint: 001372
- to stream Main, to step Merge: 003D12
- to stream Main, to step Curation: 003733
- to stream Main, to step Exploration: 003733
- to stream France, to step Extraction: 000311
Links to Exploration step
ISTEX:73A914D1D2BBC3F3D3EAEAA4B63F22CBA88776ECLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys</title><author><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name></author><author><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name></author><author><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name></author><author><name sortKey="Falardeau, Pierre" sort="Falardeau, Pierre" uniqKey="Falardeau P" first="Pierre" last="Falardeau">Pierre Falardeau</name></author><author><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bédard">Paul J. Bédard</name></author><author><name sortKey="Rostene, William" sort="Rostene, William" uniqKey="Rostene W" first="William" last="Rostène">William Rostène</name></author><author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:73A914D1D2BBC3F3D3EAEAA4B63F22CBA88776EC</idno><date when="1999" year="1999">1999</date><idno type="doi">10.1002/(SICI)1098-2396(19990601)32:3<153::AID-SYN2>3.0.CO;2-X</idno><idno type="url">https://api-v5.istex.fr/document/73A914D1D2BBC3F3D3EAEAA4B63F22CBA88776EC/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000E04</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E04</idno><idno type="wicri:Area/Istex/Curation">000E04</idno><idno type="wicri:Area/Istex/Checkpoint">001372</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001372</idno><idno type="wicri:doubleKey">0887-4476:1999:Goulet M:neurotensin:receptors:and</idno><idno type="wicri:Area/Main/Merge">003D12</idno><idno type="wicri:Area/Main/Curation">003733</idno><idno type="wicri:Area/Main/Exploration">003733</idno><idno type="wicri:Area/France/Extraction">000311</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys</title><author><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">4G2</wicri:noCountry></affiliation></author><author><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">4G2</wicri:noCountry></affiliation></author><author><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name><affiliation></affiliation><affiliation></affiliation><affiliation><wicri:noCountry code="subField">4G2</wicri:noCountry></affiliation></author><author><name sortKey="Falardeau, Pierre" sort="Falardeau, Pierre" uniqKey="Falardeau P" first="Pierre" last="Falardeau">Pierre Falardeau</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">4G2</wicri:noCountry></affiliation></author><author><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bédard">Paul J. Bédard</name><affiliation></affiliation><affiliation><wicri:noCountry code="subField">4G2</wicri:noCountry></affiliation></author><author><name sortKey="Rostene, William" sort="Rostene, William" uniqKey="Rostene W" first="William" last="Rostène">William Rostène</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>INSERM Unit 339, St.‐Antoine Hospital, 75012 Paris</wicri:regionArea><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name><affiliation></affiliation><affiliation></affiliation><affiliation><wicri:noCountry code="subField">4G2.</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Synapse</title><title level="j" type="abbrev">Synapse</title><idno type="ISSN">0887-4476</idno><idno type="eISSN">1098-2396</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="1999-06-01">1999-06-01</date><biblScope unit="volume">32</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="153">153</biblScope><biblScope unit="page" to="164">164</biblScope></imprint><idno type="ISSN">0887-4476</idno></series><idno type="istex">73A914D1D2BBC3F3D3EAEAA4B63F22CBA88776EC</idno><idno type="DOI">10.1002/(SICI)1098-2396(19990601)32:3<153::AID-SYN2>3.0.CO;2-X</idno><idno type="ArticleID">SYN2</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0887-4476</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>MPTP</term><term>Parkinson's disease</term><term>[3H]SR142948A</term><term>dopamine</term><term>dopamine agonists</term><term>in situ hybridization</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The effect of denervation with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) of the dopamine (DA) nigrostriatal pathway on neurotensin (NT) receptor and DA transporter (DAT) in basal ganglia of monkeys (Macaca fascicularis) was investigated. The MPTP lesion induced a marked depletion of DA (90% or more vs. control) in the caudate nucleus and putamen. The densities of NT agonist binding sites labeled with [125I]NT and the NT antagonist binding sites labeled with [3H]SR142948A decreased by half in the caudate‐putamen of MPTP‐monkeys. In addition, the densities of [125I]NT and [3H]SR142948A binding sites markedly decreased (−77 and −63%, respectively) in the substantia nigra of MPTP‐monkeys. Levocabastine did not compete with high affinity for [125I]NT binding in the monkey cingulate cortex, suggesting that only one class of NT receptors was labelled in the monkey brain. An extensive decrease of [3H]GBR12935 DAT binding sites (−92% vs. Control) was observed in the striatum of MPTP‐monkeys and an important loss of DAT mRNA (−86% vs. Control) was observed in substantia nigra. Treatments for 1 month with either the D1 agonist SKF‐82958 (3 mg/kg/day) or the D2 agonist cabergoline (0.25 mg/kg/day) had no effect on the lesion‐induced decrease in NT and DAT binding sites or DAT mRNA levels. The decrease of striatal NT binding sites was less than expected from the decrease of DA content in this nucleus, suggesting only partial localization of NT receptors on nigrostriatal DAergic projections. These data also suggest that under severe DA denervation, treatment with D1 or D2 DA agonists does not modulate NT receptors and DAT density. Synapse 32:153–164, 1999. © 1999 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bédard">Paul J. Bédard</name><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name><name sortKey="Falardeau, Pierre" sort="Falardeau, Pierre" uniqKey="Falardeau P" first="Pierre" last="Falardeau">Pierre Falardeau</name><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Rostene, William" sort="Rostene, William" uniqKey="Rostene W" first="William" last="Rostène">William Rostène</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000311 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000311 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:73A914D1D2BBC3F3D3EAEAA4B63F22CBA88776EC
|texte= Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys
}}
| This area was generated with Dilib version V0.6.29. |  |